Drug Trial Radar · NCT06714253
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
42
Planned (sponsor's estimate)
Start
Mar 5, 2025
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- RiboX Therapeutics Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 3, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a first-in-human clinical study to evaluate the safety, tolerability and efficacy of RXRG001 administered in the ducts of the parotid glands in adult patients with radiation-induced xerostomia (dry mouth) and hyposalivation (reduced saliva production). In Part 1 of the study (open-label, single-arm), patients will receive unilateral administrations of RXRG001 in 3 single ascending dose cohorts and in 3 multiple ascending dose cohorts. Part 2 of the study has a randomized, double-blind, placebo-controlled design. Patients will receive bilateral administrations of RXRG001 in 3 multiple ascending dose cohorts.
Conditions
- Radiation-Induced Xerostomia and Hyposalivation
Interventions
RXRG001Biological
Circular ribonucleic acid encoding human aquaporin 1 encapsulated in a lipid nanoparticle
PlaceboBiological
Placebo (saline)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse eventsTime frame: Part 1: up to 60 weeks, Part 2: up to 60 weeks
- Incidence of treatment-emergent serious adverse eventsTime frame: Part 1: up to 60 weeks, Part 2: up to 60 weeks
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Stanford Medicine
Palo Alto, California · Recruiting
University of Iowa Hospitals and Clinics
Iowa City, Iowa · Recruiting
John Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland · Recruiting
NYU Langone Medical Center
New York, New York · Recruiting
Penn Medicine - Otorhinolaryngology - Head and Neck Surgery Perelman
Philadelphia, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.